Efficacy of Difelikefalin in Subjects With Moderate-to-Severe Chronic Kidney Disease–Associated Pruritus: Pooled Subgroup Analysis of KALM-1 and KALM-2

Main Article Content

Joel Topf
Warren Wen
Catherine Munera
Frédérique Menzaghi
Michael Schömig

Keywords

efficacy, difelikefalin, CKD, pruritis

Abstract

N/A

References

1. Pisoni RL, et al. Nephrol Dial Transplant. 2006;21:3495-3505.

2. Fishbane S, et al. N Engl J Med. 2020;382:222-232.

3. Korsuva [package insert]. Stamford, CT: Cara Therapeutics, Inc.; August 2021.

4. Wooldridge TD, et al. J Am Soc Nephrol. 2020;31(suppl):22-23.

5. Mathur VS, et al. Clin J Am Soc Nephrol. 2010;5:1410-1419.

6. Phan NQ, et al. Acta Derm Venereol. 2012;92:502-507.

7. Vernon M, et al. J Am Acad Dermatol. 2020. doi:10.1016/j. jaad.2020.06.991

8. Elman S, et al. Br J Dermatol. 2010;162:587-593.